minimal sedation 2014 11 - toronto academy of dentistry › pdfs › minimal sedation handout... ·...
Post on 28-Jun-2020
7 Views
Preview:
TRANSCRIPT
14-11-24
1
Relaxed, But Not Asleep: How to use Nitrous Oxide or Oral Benzodiazepines for Effective Minimal Sedation
Dr. Carilynne Yarascavitch BSc DDS MSc (Dental Anaes) Dip ADBA
c.yarascavitch@dentistry.utoronto.ca
David After Dentist
Dangers in the Dental Office Purpose
§ Refresher for those practicing sedation § Primer for those interested § Technique Tips § Regulatory Landscape
What kind of sedation?
§ Minimal Sedation § Adults
Focus
§ RCDSO Compliance – Framework for this session
§ “Practice Ready” – Practice tips to be prepared for patients
14-11-24
2
Confidence is the feeling you have before you understand the situation. Play safe.
Objectives
§ At the end of this session, attendees will be able to: 1. Identify the clinical signs which distinguish
minimal from moderate sedation. 2. Select patients, drugs, and doses suitable for
the goal of minimal sedation. 3. Establish policies and practices in their office
which comply with RCDSO regulations.
Objective 1
Identify the clinical signs which distinguish minimal from moderate sedation.
What is “Sedation” ?
§ Sedation – Suppression of arousal and behaviour – Decrease in activity
§ Anxiolysis – Ability to decrease anxiety
§ Amnesia – Ability to impair memory
§ Hypnosis – Ability to produce drowsiness and facilitate
onset and maintenance of sleep
Continuum Depth of Sedation
Clinical Effect Minimal ðModerate ðDeep ðGA
Sedation Anxiolysis Amnesia Hypnosis
14-11-24
3
Minimal vs Moderate Sedation
§ Minimal sedation – Sedation, anxiolysis
• amnesia – Comfortable and relaxed – May experience natural sleep – Conscious at all times – Respond purposefully to
verbal and tactile simulation
Minimal vs Moderate Sedation
§ Moderate sedation – Sedation, anxiolysis
• amnesia, MILD hypnosis – Comfortable and relaxed – May be drowsy – Conscious at all times – Respond purposefully to repeated
verbal and tactile stimulation
§ Use of Sedation and General Anaesthesia In Dental Practice (Approved by Council June 2012)
§ Minimal standards for the use of sedation
RCDSO Standards of Practice Overview Guidelines to Standards of Practice
§ Older “Guidelines”: Definitions of sedation combine route of administration with depth – “Oral conscious sedation”
§ 2012 “Standards of Practice”: RCDSO revisions demphasize route of administration and emphasize depth (clinical effect) independent of route of administration – “Minimal, Moderate, Deep”
Conscious Sedation “…a minimally to moderately depressed level
of consciousness that retains the patient’s ability to independently and continuously
maintain an airway and respond appropriately to physical stimulation and
verbal command.”
Minimal Sedation “…responds normally to tactile
stimulation and verbal commands. Although cognitive function and coordination may be modestly
impaired, ventilatory and cardiovascular functions are
unaffected.”
Moderate Sedation “…responses purposefully to verbal commands, either alone or by light tactile stimulation. No interventions are required to maintain a patient
airway and spontaneous ventilation is adequate. Cardiovascular function is
usually maintained.”
RCDSO Standards of Practice Part I – Conscious Sedation RCDSO Standards of Practice
§ If we define level of sedation by clinical effect, does route of administration matter? – Yes. – Route matters for facility permits and
provider registration because the RCDSO makes assumptions about sedation depth based on • the route you use** • the doses you provide**
14-11-24
4
How do I know if I am doing minimal or moderate? 1) Clinically by assessing the patients level
of consciousness using response to voice/touch
– Immediate – minimal – Repeated – moderate
2) Artificially by route as defined by our RCDSO regulator* – Multiple oral drugs – IV = moderate
RCDSO Appendix III Characteristics of the Levels of Sedation
MINIMAL SEDATION
MODERATE SEDATION
DEEP SEDATION
GENERAL ANAESTHESIA
CONSCIOUSNESS Maintained Maintained Reduced Unconscious
RESPONSIVENESS To either verbal or
tactile
May require one or both verbal
and tactile
Response to repeated or
painful stimuli
Unrouseable, even to pain
AIRWAY Maintained No intervention required
Intervention may be required
Intervention usually required
PROTECTIVE REFLEXES Intact Intact Partial loss Assume absent
SPONTANEOUS VENTILATION Unaffected Adequate May be
inadequate May be
impaired
CARDIOVASCULAR FUNCTION Unaffected Usually
maintained Usually
maintained May be
impaired REQUIRED
MONITORING Basic Increased Advanced advanced
Differential Diagnosis Characteristics of the Levels of Sedation
MINIMAL SEDATION
MODERATE SEDATION
DEEP SEDATION
GENERAL ANAESTHESIA
HOW DO THEY RESPOND?
Voice OR Touch?
Voice AND touch?
REPEATED voice and touch
or PAIN?
NO RESPONSE
AIRWAY No change NO SUPPORT required
SUPPORT required:
Head tilt, chin lift
Intervention required
BREATHING No change SOMETIMES
Slower, smaller breaths
USUALLY Slower, smaller
breaths
Slowest, smallest or NO
breaths
CIRCULATION No change Small changes Moderate changes Big changes
PATIENT MONITORING Basic Increased EXPERT EXPERT
How do they respond? Verbal Indicators of Depth of Sedation
§ Immediate answers § Speech is clear § Speech makes sense § Delayed answers § Nonsensical responses § Incoherent speech § No response
Levels of Sedation
Scenario Effect Clinically Legally 69 yo F 50 kg ASA II Triazolam 0.125 mg
• Responds to light touch
• No snoring • RR10, HR 80
BP 120/80
Minimal Minimal
69 yo F 50 kg ASA II Midazolam 1 mg IV
• Responds to voice
• RR8, HR 70 BP 110/72
Minimal Moderate
Levels of Sedation
Scenario Effect Clinically Legally 35 yo F 50 kg ASA II Triazolam 0.5 mg
• No response to voice, but responds if touched
• Snoring sound
Moderate Moderate
35 yo F 50 kg ASA II Triazolam 0.5 mg
• Groans if pinched • Snoring when you
lift chin, no sound if you don’t
Deep !
14-11-24
5
What depth of Sedation?
§ 18 yo F 72 kg ASA II § Triazolam 0.375 mg § Pre-op VS: BP 128/68, HR 79, RR 12
§ Tap lightly on the shoulder for verbal response § Respond normally to your questions § Light snoring when not stimulated § Relaxed breathing § BP 130/70, HR 75, RR 12
§ Minimal Sedation
What depth of Sedation?
§ 25 yo F 90 kg ASA II § Triazolam 0.5 mg § Pre-op VS: BP 132/80, HR 78, RR 12
§ Responds when you touch and call their name § Response is slow § Speech is slurred but answers may sense § Loud snoring when not stimulated § BP 120/80, HR 70, RR 8
§ Moderate Sedation
What depth of Sedation?
§ 38 yo F 90 kg ASA II § Triazolam 0.5 mg § Pre-op VS: BP 120/72, HR 68, RR 12
§ Pinching shoulder causes movement § Heavy snoring unless chin is lifted § Belly is tense and moves strangely without chin lift § BP 110/60, HR 72, RR 9
§ Deep Sedation
What depth of Sedation?
§ 57 yo F 72 kg ASA II § Triazolam 0.25 mg § Pre-op VS: BP 120/80, HR 70, RR 10
§ Responds when you call their name § Response is normal with clear speech § Quiet breathing § BP 120/80, HR 70, RR 10
§ Minimal Sedation
What depth of Sedation?
§ 62 yo F 90 kg ASA II § Triazolam 0.5 mg § Pre-op VS: BP 120/72, HR 68, RR 12
§ No response to name, no response with jaw thrust § No breath sounds unless jaw is thrusted upward § Relaxed belly that doesn’t appear to be moving much § BP 90/60, HR 90, RR 6
§ General Anaesthesia
Objective 2
Select patients, drugs, and doses suitable for the goal of minimal sedation.
14-11-24
6
Patient Selection
§ Sedation techniques – “are to be used only when indicated, as an
adjunct to appropriate non-pharmacological means of patient management” p.2
RCDSO Standards of Practice General Standards
Indication for Sedation
§ Fear or Anxiety § Poor Cooperation
– Mentally Challenged – Cognitively Impaired – Motor Dysfunction – Gag Reflex
§ Extensive Procedure
§ Document it!
§ “Adequate, clearly recorded current medical history” (#4, p.2) – present and past illnesses – hospital admissions – current medications – non-prescription drugs – herbal supplements – allergies
RCDSO Standards of Practice Professional Responsibilities
§ “Adequate, clearly recorded current medical history” (#4, p.2) – Functional inquiry* – Physician consult for medically
compromised patients – Reviewed for changes at each sedation
appointment
RCDSO Standards of Practice Professional Responsibilities
§ “Core medical history” – Must elicit the core medical information to
enable the dentist to assign the correct ASA Classification
– Should be system-based review of past and current health status (see RCDSO’s sample medical history questionnaire)
– Supplemented with questions relevant to the use of sedation
RCDSO Standards of Practice Appendix I
14-11-24
7
Functional Inquiry
§ Investigates potential concerns from the medical history.
§ Your functional inquiry should include a review of systems affected, and notations on any investigations.
§ The goal is to ask questions which help you to assess severity and stability, in order to form an impression of the effect of systemic disease on the patient’s health and potential impact on treatment.
Functional Inquiry
§ What is/are the diagnosis/diagnoses? – Estimate date of diagnosis or initial presentation
§ What underlying body systems does it affect? – Review the body system for sign/symptoms of disease
§ Do you need more information? – Gather investigations such as chairside tests e.g. blood
glucose, medical letters § What is your impression of the severity/stability?
– Ask questions to determine effects on the body systems and disease progression, limitations in daily function, and changes in quality of life
Functional Inquiry Review of Systems § CNS – central nervous system: epilepsy, stroke, TIA § CVS – cardiovascular: hypertension, coronary artery
disease § RESP – respiratory: asthma, COPD § DERM – dermatological: eczema § ENDO – endocrine: diabetes, thyroid § GI – gastrointestinal: liver, HEPATIC § GU – genitourinary: kidney, RENAL § HEME – hematological: bleeding disorders, anemia § MSK – musculoskeletal: joint replacement, arthritis, osteoporosis § PSYCH – psychological: depression, bipolar disorder, anxiety disorder § SH – modifiable lifestyle factors: smoking, alcohol, recreational drugs
General Review of Systems Important for any disease process § Precise medical condition
– Estimated date of diagnosis § How is this condition managed?
– Medications? Diet? Surgery? – No intervention (observation only)?
§ Follow-up medical care – Does the patient see their MD or specialist for this
condition? – How often? – Last seen? – What was MD’s last recommendation?
General Review of Systems Important for any disease process § Symptoms patient experiences
– Does the patient have symptoms? – What are the symptoms?, When do they occur?, – When did they last occur?, What about the time
before last? • Asking for both most recent and the previous time allows
better estimation of frequency of events, which can help determine stability.
§ Has this condition ever required hospitalization? § Effect on daily life
– Can the patient engage in normal activities or do they have to reduce or change activities because of their disease?
§ “A determination of the patient’s American Society of Anesthesiologists (ASA) Physical Status Classification as well as consideration of any other factors that may after his/her suitability for sedation must be made prior to its administration.” (#5, p.2) – #1 other factor to consider: Sleep Apnea
RCDSO Standards of Practice Professional Responsibilities
14-11-24
8
ASA Physical Status Classification System
I A normal healthy patient II A patient with mild systemic disease III A patient with severe systemic disease IV A patient with severe systemic disease that is a
constant threat to life V A moribund patient who is not expected to survive
without the operation E A declared brain-dead patient whose organs are
being removed for donor purposes
ASA Status: Asthma
§ Uses puffer daily, last asthma attack 2 years ago – ASA II
§ Active wheezing with expiration, difficulty breathing – ASA IV
§ Uses puffer daily, last asthma attack 1 week ago, FEV1 consistently < 80% baseline – ASA III
ASA Status: CAD
§ HTN, obese, severe chest pain at rest yesterday, extreme SOB with minimal exertion 2 days ago – ASA IV
§ HTN, obese, SOB climbing 3 stairs, takes breaks – ASA III
§ HTN, 20 pack-year smoker, runs daily – ASA II
§ “Core Physical Examination” – Current basic physical examination – General appearance, noting abnormalities – Taking and recording of vital signs i.e.
heart rate and blood pressure – Appropriate airway assessment
RCDSO Standards of Practice Appendix I
Basic Physical Exam Heart Rate § Heart Rate = # beats/min § Normal Resting HR (Adults)
– 60 to 100 bpm
§ Bradycardia – < 60 bpm
§ Tachycardia – > 100 bpm
Basic Physical Exam Blood Pressure For a patient without a pre-existing diagnosis:
– Normal Blood Pressure • 120/80
– Prehypertension • 120-139/80-89
– Hypertension • >140/90
For a patient diagnosed with hypertension, targets: – <140/90 – <130/80 for Diabetics, Renal disease
14-11-24
9
Basic Physical Exam Respiratory Rate § Respiratory Rate = # breaths/min
§ Normal Respiratory Rate (Adults) – 8-12 breaths/min
§ Tachypnea – > 12 breaths/min
§ Bradypnea – < 8 breaths/min
§ Respiratory Arrest – 0 breaths/min
Functional Inquiry Example 1
50 year-old M for periodontal treatment. Appears healthy and well-nourished, Ht 176 cm, Wt 70 kg BMI=22.6 (healthy wt). Dentally anxious (4/5). BP 110/70, HR 76. § CVS: HTN (Diagnosed 2004) § ROS: Treated with medication Zestoretic, pt compliant with
medication § Pt denies SOB, CP, SOA, palpitations, TIA/Stroke. Daily exercise
30 min run 3x/wk. § INV: MD letter March 2013 “well controlled” § IMP: Mild, stable HTN § ASA: II
Functional Inquiry Example 2
45 year old F prosthodontic needs, anxious regarding dental treatment (3/5). Ht is 155 cm, Wt 70 kg, BMI=29.1 (overweight). Appears healthy/active. BP 140/75 HR 98. § ENDO: DM2 (Diagnosed 15 yrs ago) § ROS: Meds: Metformin and Glyburide, pt does not always
remember to take. Hospitalized 1x 10 yrs ago hypoglycemic attack with seizure, no sequelae; last hypoglycemic episode 3 months ago “felt dizzy”, took oral carbohydrate, “felt fine after”, no episodes since. Complications: retinopathy, numbness in feet, followed by TGH endocrinologist Dr. Barry q3 months.
§ INV: Blood sugar ranges 9-12 mmol/L; HbA1c 10.4, MD reports “poorly controlled” (MD letter Dec 13)
§ IMP: Pt has complications – mod severity; Pt has hypoglycemic episodes and poor blood sugar control - stability questionable.
Functional Inquiry Example 2
45 year old F prosthodontic needs, anxious regarding dental treatment (3/5). Ht is 155 cm, Wt 70 kg, BMI=29.1 (overweight). Appears healthy/active. BP 140/75 HR 98. § CVS: HTN and hyperlipidemia (Dx approximately June 2012) § ROS: Treated with Coversyl and Atorvastatin, SOB with heavy
exercise, denies angina, palpitations, SOA, TIA/stroke, no hospitalizations. Can walk 2 flights stairs without stopping.
§ INV: MD letter Dec 13 BP 144/84 “poor control” § IMP: Target BP for diabetes should be <130/80; pt has
inadequate risk reduction for MI/Stroke.
§ Summary IMP: Poorly controlled DM2 and HTN with questionable stability
§ ASA II +? ASA III?
Functional Inquiry
§ Core Functional Inquiry for Sedation
§ Respiratory System § Cardiovascular System § AIRWAY
Functional Inquiry “Airway” 2 Must-ask Questions: 1. Are the nares patent? 2. Any diagnosis of sleep apnea? 1 “Maybe” Question: 3. Malampatti view
14-11-24
10
UPPER AIRWAY ANATOMY Functional Inquiry “Airway” § In the conscious state,
– Tonic and reflex inspiratory activity in the genioglossus keeps the tongue away from the posterior pharyngeal wall
– Tonic activity in the levator palati, tensor palati, palatopharyngeus and palatoglossus prevents the soft palate from falling back against the posterior pharynx
Obstruction by the tongue and epiglottis.
. Circulation 2000;102:I-22-I-59
Copyright © American Heart Association, Inc. All rights reserved.
STOP-BANG Questionnaire (Chung et al, 2008) Obstructive Sleep Apnea Screening Please answer the following questions to the best of your ability. Yes No S Do you snore loudly (louder than talking or loud enough to hear
through a closed door?) T Do you often feel tired, fatigued, or sleepy during the daytime? O Has anyone observed you stop breathing during your sleep? P Do you have or are you being treated for high blood pressure? For Doctor’s Use. B BMI >35 kg/m2
A Age >50 years N Neck circumference >40 cm G Gender M
2 STOP + 2 BANG – high risk sleep apnea - DO NOT TREAT 2 STOP + 1 BANG – possible sleep apnea 2 STOP + 0 BANG – low risk sleep apnea
Mallampati Classification § Popular predictor for difficult airway management (modified by Samsoon & Young 1987) is a
§ Basis: visibility of oral & pharyngeal structures with paEent siFng in upright posiEon, mouth fully opened, tongue fully extended, without phonaEon
§ I & II: Easy § III & IV Difficult
Malampati Classification
§ I & II = easy airway § III & IV = difficult
14-11-24
11
Functional Inquiry “Airway” 2 Must-ask Questions: 1. Are the nares patent?
– Delivery of nitrous oxide, supplemental oxygen
2. Any diagnosis of sleep apnea? – Relative contraindication to minimal sedation – Nitrous oxide best choice
1 “Maybe” Question: 3. Malampatti view
• Class IV may be difficult to rescue from over-sedation
Drug Selection
How do I know if I am doing minimal or moderate? 1) Clinically by assessing the patients level
of consciousness using response to voice/touch
– Immediate – minimal – Repeated – moderate
2) Artificially by route as defined by our RCDSO regulator* – Multiple oral drugs – IV = moderate *more on this now
§ Specific standards for particular modalities 1. N2O 2. Oral single sedative drug 3. Oral single sedative drug + N2O 4. Oral multiple sedative drugs (+/- N2O) 5. Parenteral (IV) 6. Deep Sedation
RCDSO Standards of Practice Overview
1. Administration of nitrous oxide and oxygen ALONE
2. Oral administration of a SINGLE sedative drug
3. Combination of 1 & 2 – IF minimal sedation is your intent – AND symptoms reflect an effect of
minimal sedation
What modalities are considered by the RCDSO to produce minimal sedation?
1. Oral administration of multiple sedative drugs
2. Administration of a sedative drug (s) by any parenteral route:
• Intravenous • Intramuscular • Subcutaneous • Submucosal • Intranasal
What modalities are considered are by the RCDSO to produce moderate sedation?
14-11-24
12
Sedation Medications
Route/Modality Onset Titrate Duration Reversal Inhalational Rapid Rapid Controlled Easy
Oral Slow No Prolonged Hard Intravenous Rapid Rapid Prolonged Possible
Sedation Medications
Route/Modality Onset Titrate Duration Reversal Inhalational Rapid Rapid Controlled Easy
Oral Slow No Prolonged Hard Intravenous Rapid Rapid Prolonged Possible
Nitrous Oxide
N2O Properties
§ Sedation § Analgesia
N2O Pharmacokinetics
§ Blood gas coefficent Pb/g-0.47 – Low solubility in blood – Rapid uptake – Rapid elimination
§ 0.004% biotransformation in GI tract – Excreted almost entirely unchanged
N2O Pharmacodynamics
§ MAC = 104 – Low potency
• At 104% Nitrous Oxide, 50% of patients experience general anaesthesisa
• Between 20-50% Nitrous Oxide, patients experience conscious sedation
§ Cardiovascular Effects – Weak myocardial depressant – Mild sympathomimetic
• Minimal overall effect
14-11-24
13
N2O Pharmacodynamics
§ Respiratory Effects – Weak respiratory depressant (êvolume) – Mild sympathomimetc (érate)
• May potentiate other agents • Healthy Patients: Minimal overall effect
– Decreased central hypercapnic response (C02) – Decreased peripheral hypoxemic response (O2)
• Severe COPD patients can experience respiratory arrest
N2O Contraindications
§ Nasopharyngeal obstruction § Severe COPD § Closed Tissue Spaces § Belomycin chemotherapy § Claustrophobia § Vitreoretinal surgery within 3 months
N2O Contraindications § Nasopharyngeal obstruction
– Can you easily breathe through your nose? – Do you commonly get nasal congestion?
§ Severe COPD – Have you ever been told you should have home
oxygen? § Closed Tissue Spaces
– Do you have middle ear disease?
N2O Contraindications § Bleomycin chemotherapy
– Have you ever been treated with bleomycin? • IV, IM, or SubQ antibiotic chemotherapy • Lymphoma, testicular or squamous cell?
§ Claustrophobia – Do you get anxious in confined spaces?
§ Vitreoretinal surgery within 3 months – Have you had eye surgery in the past 3 months? – If so, what type? – Perfluoropropane C3F8 or Sulfurhexafloride SF6
Is this a good choice?
§ Can you minimize leaks? (maximize dose) – Use a rubber dam? – Will patient exhale through their nose not mouth?
§ Is your patient likely to enjoy? – Finds alcohol relaxing? – Misinterpret symptoms as disturbing?
§ Procedural Considerations – Will the nasal hood be in the way?
Benzodiazepines
14-11-24
14
BDZ Properties
§ Agonists of BDZ subunit GABA receptor
§ Anxiolysis § Sedation § Amnesia § Muscle Relaxants § Anticonvulsants
BDZ Pharmacokinetics
§ Absorption – Delayed – Average of 60 to 30 minutes – PO and SL routes have different effect
• PO routes have a “first pass” through the liver before entering the systemic circulation (where they affect the brain)
• Happens because venous blood from the intestine (where the drug is absorbed) enters the liver first
• Dose reduction ~30% if given sublingual
BDZ Pharmacokinetics
§ Distribution – First to VRG (Brain) then Muscle and Fat
§ Biotransformation (Liver) – Chemical transformation of the drug by enzymes – Enzymatic degredation by Cytochromes P450;
CYP3A4 and CYP2D6 § Elimination (Kidney)
– For a single dose, 4 half-lives are necessary before a drug is 90% eliminated.
BDZ Pharmacodynamics
§ Systemic effects negligible
§ Cardiovascular Effects – Minimal myocardial depression – High doses á HR â BP
§ Respiratory Effects – Minimal âRR â Volume as single agent – High doses â Hypoxic drive
Typical BDZ for Dentistry
§ Triazolam (Halcion) § Diazepam (Valium) § Lorazepam (Ativan) § Alprazolam (Xanax) § Temazepam (Restoril) § Oxazepam (Oxpam)
Benzodiazapine Contraindications
§ Sleep Apnea § Paradoxical Reactions
14-11-24
15
Is this a good choice?
§ Can your patient swallow pills? – Or do they need to be crushed/ground?
§ How is that airway? – Respect for sleep apnea!
Dose Selection
Optimizing Dose
Amount of Drug è
Effe
ct o
n B
ody
è
Desired Effect
Side Effect N2O Dose Selection
N2O Ideal Sedation Symptoms Signs Relaxation Decreased muscle tone Light-headedness Transient increase in HR, BP Tingling of hands, feet, lips Normal respiration Warmth Periphreal vasodilation Light “floating” to heavy “sinking” feeling Mild euphoria
N2O Over-Sedation Symptoms Signs Laughing Restlessness Dreaming Sweating Tearing/crying Tearing/lacrimation Nausea Vomiting Dysphoria Persistent increase in HR, BP, RR
14-11-24
16
Nitrous Oxide % Dose Selection
§ 20% is a good starting point § 20-40% most patients enjoy distracting and
pleasant effects § >50% most patients experience side effects,
especially nausea/vomiting § 70% may be required for some patients to feel
any effect, but this is rare – Check for leaks!
BDZ Dose Selection
BDZ Dose Considerations
§ Weight § Age § Systemic health § Concurrent medications § Chemical dependency § Anxiety level
Triazolam Properties Time (hours)
Onset of Action 0.5-1
Peak Serum Concentration 1-2
Duration of Action ~2
Elimination Half Life 1.5-5.5
Best for Appointments <3
Available Oral Preparations 0.125 and 0.25 mg tablets
Dose Range 0.125-0.5 mg (0.004 mg/kg)
Diazepam (Valium) Properties Time (hours)
Onset of Action 0.5-1
Peak Serum Concentration 0.5-2
Duration of Action 2-4
Elimination Half Life 20-80
Best for Appointments >2
Available Oral Preparations 2, 5, and 10 mg tablets
Dose Range 10-30 mg (0.065-0.3 mg/kg)
Lorazepam (Ativan) Properties Time (hours)
Onset of Action 1-2
Peak Serum Concentration 1-6
Duration of Action Up to 8
Elimination Half Life 10-20
Best for Appointments >3
Available Oral Preparations 0.5, 1, and 2 mg po and sl tablets
Dose Range 0.5-3 mg (0.02 mg/kg)
14-11-24
17
Alprazolam (Xanax) Properties Time (hours)
Onset of Action 1-1.5
Peak Serum Concentration 1-2
Duration of Action 4-6
Elimination Half Life 6-30
Best for Appointments >3
Available Oral Preparations 0.25, 0.5, 1 and 2 mg tablets
Dose Range 0.25-0.5 mg
Temazepam (Restoril) Properties Time (hours)
Onset of Action 0.5-1
Peak Serum Concentration 1.2-1.6
Duration of Action ~4
Elimination Half Life 3.5-18.4
Best for Appointments Data not available
Available Oral Preparations 15 and 30 mg capsules
Dose Range 7.5-30 mg
Oxazepam (Oxpam) Properties Time (hours)
Onset of Action ~1
Peak Serum Concentration ~2
Duration of Action ~3
Elimination Half Life ~8
Best for Appointments Data not available
Available Oral Preparations 10, 15, and 30 mg capsules
Dose Range 10-30 mg
Approximate Doses ASA I/II Patients
Drug Minimal Moderate Night Before Triazolam (Halcion) 0.125-0.25 mg 0.375-0.50 mg 0.125-0.25 mg
Diazepam (Valium) 10-15 mg 20-30 mg 5-10 mg
Lorazepam (Ativan)
0.5-1 mg 2-3 mg -
Alprazolam (Xanax) 0.25 mg 0.5 mg 0.25 mg
Temazepam (Restoril) 15 mg 20-30 mg -
Oxazepam (Oxpam) 10-15 mg 15-30 mg -
BDZ Dose Selection
STEP 1: What is my sedation goal? – Minimal sedation
STEP 2: Begin with a weight-based dose – This is your starting point
STEP 3: Consider dose modifiers – Age/health status? – Liver enzymes? – Anxiety level? – Special reason to be cautious?
BDZ Dose Selection
§ Weight – Use “ideal” not actual body weight – Must dose to lean body mass to avoid overdose
Ideal body weight (BMI): http://www.halls.md/ideal-weight/body.htm (Or estimate)
14-11-24
18
BDZ Dose Selection
Liver enzymes? § Enzyme induction? = need more drug
– Smoking/alcohol abuse – Daily benzodiazepines?
§ Enzyme inhibition? = need less drug – CYP3A4 inhibitors: erythromycin, clarithromycin,
azole antifungals, cimetidine, grapefruit juice – Age, poor systemic health
BDZ Dose Selection
Anxiety level? § Mild anxiety?
– Stick to weight dose § Moderate anxiety?
– Modest increase in dose
Example: Triazolam
40 yo F 5’4” (64cm) 210 lbs (95kg) Healthy, Non-drinker, Smokes ½ pack/day Very anxious!
0.004 mg/kg x 90kg = 0.38 mg Pt is a heavy smoker and highly anxious, perhaps consider an increase in dose for a minimal sedation effect?
Closest dose = 0.5 mg
Example: Triazolam
40 yo F 5’4” (64cm) 210 lbs (90kg) Healthy, Non-drinker, Smokes ½ pack/day Very anxious!
Ideal body wt (based on BMI): 111-146 lbs For this example, assume 140 lbs; = 64 kg Actual wt: 0.004 mg/kg x 90 kg = 0.38 mg Ideal wt: 0.004 mg/kg x 64 kg = 0.25 mg Closest dose? = 0.375 mg NOT 0.5 mg
Triazolam Dose for Minimal Sedation
I recommend 3 Triazolam dosing strategies: 0.125 mg 0.250 mg 0.375 mg (0.5 mg)
Triazolam Dose for Minimal Sedation
Rationale for Triazolam dosing strategies: Dose Explanation 0.125 mg* Usually poor effect for healthy patients with moderate anxiety; Use
for elderly, fragile (medically compromised), small patients based on ideal body weight.
0.250 mg* Likely good effect; base on ideal body weight. May be unsatisfactory for highly anxious patients or those with enzyme induction (current benzodiazepine, alcohol, or smoking)
0.375 mg** May be minimal sedation when at previous appointment effect for 0.250 mg demonstrated to have limited or no effect.
(0.5 mg) Most likely moderate sedation; avoid this dose.
*RCDSO recommended minimal sedation doses **Possible moderate sedation – monitor effect closely to ensure minimal
14-11-24
19
Continuum Depth of Sedation
§ It is not always possible to predict how a patient will respond
§ Individuals administering sedation need to be able to rescue patients who enter a state of deeper sedation than intended
Examples of Minimal Sedation
§ 40% N2O:O2 § 0.25 mg triazolam § 0.125 mg triazolam + 30% N2O:O2 And….
patient answers you intelligibly when you ask a question. You may have to gently touch them, but they will respond rapidly and sensibly.
Objective 3
Establish policies and practices in their office which comply with RCDSO regulations.
General Categories of Regulations
§ Training and Education § Provider and Facility Permits § Facility Resources § Patient Evaluation § Documentation § Emergency Preparedness
Training & Education
Assumptions of Regulators
Sedation Minimal Moderate Deep Modality • N2O alone
• 1 drug • 1 drug + N2O
• Multiple oral medications
• IV
• Ketamine • Propofol
Monitoring Basic Increased Advanced
Training Basic Increased Advanced
14-11-24
20
§ “Successful completion of a training program designed to produce competency in the specific modality of sedation utilized is mandatory.” (#1, p.2) – Document your continuing education – Include this course in your training
RCDSO Standards of Practice Professional Responsibilities
§ “Training program must be obtained from one or more of the following sources” (i, p.6) – Undergraduate or postgraduate program – Continuing education courses
• Teachers certified sedation/anesthesia • Permit candidates to utilize techniques**
RCDSO Standards of Practice Professional Responsibilities
§ “Followed by a recorded assessment of the competence of candidates.” (i, p.6)
• Course where you have taken a test**
RCDSO Standards of Practice Professional Responsibilities
Provider & Facility Permits
Do I need a provider permit for minimal sedation with.. § Oral benzodiazepines?
– No. § Nitrous Oxide and Oxygen Sedation?
– No.
Do I need an office inspection for minimal sedation with… § Oral benzodiazepines?
– No. § Nitrous Oxide and Oxygen Sedation?
– No.
14-11-24
21
Facility Resources
§ “In order to avoid allegations of sexual impropriety, additional appropriate staff should be present in the treatment room at all times whenever sedation is used.” (#11 p.4) – Alter cognition – Dream-like state – Sexual phenomena
RCDSO Guidelines Section????
§ “1. Administration of Nitrous Oxide and Oxygen”
§ Gas delivery system – Scavenging – Separate reserve “E” cylinder of oxygen – Written record of annual maintenance/
servicing kept on file for review as required
RCDSO Standards of Practice Additional Standards
§ “All automated monitors must receive regular service and maintenance by qualified personnel according to their manufacturer’s specifications, or annually, whichever is more frequent.”
§ “A written record of this annual maintenance/servicing must be kept on file for review by the RCDSO as required.”
RCDSO Standards of Practice Sedation Equipment (p.9)
Mandatory Equipment
§ Standard Emergency Medications + – Reversal Agents (Flumazenil) – Ensure E-tank Oxygen (+Face Mask)
§ Blood Pressure Monitior – Manual stethescope and sphygomanometers of
appropriate sizes
§ Pulse Oximeter* – Audio alarm settings
*N/A nitrous alone, single oral agent alone
Pulse Oximetry
§ The pulse oximeter is an essential monitor for dentists who provide sedation
n Introduced in the 1980’s n Noninvasive, inexpensive, simple monitor
of respiratory function n Detects hypoxemia (↓oxygen in blood)
14-11-24
22
How it works (3) – Physiology (A)
§ Hemoglobin is the active oxygen-carrying part of the erythrocyte (red blood cell)
§ If all 4 Hb molecules bind with oxygen, there is 100% saturation
Physiology (B)
§ Pulse oximeters measure arterial oxygen saturation, (SaO2) which is the affinity for oxygen binding to hemoglobin and physiologically related to arterial oxygen tension (PaO2) according to the oxyhemoglobin (HbO2) dissociation curve
Physiology (B)
§ If the oxygen unloads from the Hb molecule to the tissues and is not replaced, the hemoglobin saturation falls
Limitations (1)
§ Measures oxygen saturation, NOT content, therefore cannot provide actual measure of tissue oxygenation
Limitations (2)
§ Signal processing § Ambient light § Low perfusion § Motion artifact
§ IV Substances § Dyshemoglobins § Intravenous dyes
§ Pigmentation § Skin § Nail polish
§ “2. Oral Administration of a Single Sedative Drug” Additional Responsibilities (p. 8) – Emergency Equipment
• Full face masks of appropriate size and connectors
• Fumazenil
RCDSO Standards of Practice
14-11-24
23
Essential Emergency Drugs
DA Haas, Dent Clin N America, 2002
N2O Reversal: 100% Oxygen
EASY!
BDZ Reversal: Flumazenil (Anexate)
§ Antagonizes effect of benzodiazepines on GABA receptor in the CNS
§ Contraindicated in patients given benzodiazepine for control of epilepsy
§ 0.1 mg/mL ONLY IV 0.1-0.2 mg increments § Onset 1-2 min, peak 6-10 min, duration 45
min (less than duration of benzodiazepine) therefore caution to monitor and re-dose
§ Have the drug in your kit, call EMS, and let the paramedics deliver it for you.
Patient Evaluation
§ “Dentists must take into account the maximum dose of local anaesthetic that may be safely administered, especially for children, the elderly and the medically compromised.” (p.4)
RCDSO Guidelines Professional Responsibilities
§ “Whenever sedation is used, the calculated maximum dose of local anaesthesia may need to be further adjusted to provide a greater margin of safety” (p.4) – Implies you calculate the maximum dosage
of LA for each patients – Do you?!?!
RCDSO Guidelines Professional Reponsibilities
14-11-24
24
Calculating Max LA Dose
§ Patient-specific § Based on patient weight § # of cartridges simple way to keep track
3 Steps Max LA Dose
Step 1. How many milligrams of drug are in one cartridge? – Need to know
• concentration of drug (%) • volume of cartridge you use (ml)
Step 2. What is the maximum dose for this patient? – Need to know
• weight of patient (kg) • maximum recommended dosage of drug (mg/kg)
Step 3. How many cartridges can I give? – Max dose (mg)/Amount drug (mg) per cartridge = # cartridges
Step 1: How many mg of LA in 1 Cartridge? § What percent concentration is your solution?
– i.e. Lidocaine 2%
§ Percent solutions represent grams per 100 ml – i.e. 2% lidocaine = 20 mg/ml
§ 1 North American cartridge = 1.8 ml – 20 mg/ml x 1.8 ml = 36 mg of lidocaine
Step 2: Maximum dose for your patient (mg)
Maximum Recommended Dose mg/kg (MAX)
Local Anaesthetic
Adult
Articaine 4% 7 mg/kg (500 mg)
Lidocaine 2% 7 mg/kg (500 mg)
Mepivicaine 2% (with
vasoconstrictor)
6.6 mg/kg (400 mg)
Mepivicaine 3% (plain)
7 mg/kg (400 mg)
Prilocaine 4% 8 mg/kg (500 mg)
DA Haas, J Can Dent Assoc, Oct 2002
Step 2: Maximum dose for your patient (mg)
Pt Wt MRD Max Dose Pt Articaine
Adult 90 kg 7 mg/kg 630 mg 500 mg
Lidocaine Adult 90 kg 7 mg/kg 630 mg
500 mg
Step 3: Maximum dose for your patient (cartridge)
§ Lidocaine 2% – 500 mg is the MRD for a 90 kg patient – 2% lidocaine has 36 mg in 1 cartridge
– 500/36 = 13
– Maximum number of cartridges of 2% lidocaine is 13.
14-11-24
25
§ “All patients must be specifically assessed for fitness for discharge” (iv, p.6)
RCDSO Standards of Practice Discharge Fit for Discharge?
§ Alert § Oriented § Ambulatory § Recovering § Pain/Bleeding managed § Returned to the same condition as upon arrival
§ “1. Administration of Nitrous Oxide and Oxygen” Additional Standards (p.8)
• “Only fully recovered patients can be considered for discharge unaccompanied.
• If discharge occurs with any residual symptoms, the patient must be accompanied by a responsible adult.”
RCDSO Standards of Practice Additional Standards
§ “1. Administration of Nitrous Oxide and Oxygen” Additional Standards (p.7)
§ “Recovery status post-operatively must be specifically assessed and recorded by the dentist, who must remain in the facility until that patient is fit for discharge.”
RCDSO Standards of Practice Additional Standards
§ “2. Oral Administration of a Single Sedative Drug” Additional Responsibilities (p. 8) – Discharged when
• Oriented (person, place, time) • Ambulatory • Vital signs stable (baseline) • Signs of increasing alertness
RCDSO Standards of Practice
§ “2. Oral Administration of a Single Sedative Drug” Additional Responsibilities (p. 8) – Discharged to
• The care of a responsible adult – Discharged with
• Postoperative W/V instructions
RCDSO Standards of Practice
14-11-24
26
Documentation
Informed Consent
§ Separate written consent § Discussion about the medication and its
expected effects – Relaxed, not asleep – Fuzzy memories (BDZ)
§ Written Pre-operative and Post-operative instructions explained
§ “1. Administration of Nitrous Oxide and Oxygen” (p.7) Can be administered by – Trained dentist – Trained registered nurse (RN, RPN)/
respiratory therapist (RT) • Dentist is present/immediately available • Patient received N2O sedation before • Dosage levels previously determined
and recorded by the dentist in pt chart
RCDSO Standards of Practice Additional Standards
§ “1. Administration of Nitrous Oxide and Oxygen” (p.7) – Direct and continuous monitoring by DDS,
RN, or RT (Note: cannot be monitored by a hygenist – DDS, RN or RT must always be in the room)
– Never left unattended by DDS, RN or RT
RCDSO Standards of Practice Additional Standards
§ “1. Administration of Nitrous Oxide and Oxygen” Additional Standards (p.7) – “….continuous clinical observation for level
of consciousness and assessment of vital signs which may include heart rate, blood pressure, and respiration preoperatively, intraoperatively, and postoperatively, as necessary”
RCDSO Standards of Practice Additional Standards
§ “2. Oral Administration of a Single Sedative Drug” Additional Responsibilities (p. 8) – Dose administered in-office
• Except 1: facilitate sleep the night before • Except 2: sedation permits office arrival
– Accompanied to* and from the office – Monitored by clinical observation of the
• level of consciousness • assessment of vital signs (HR, BP, RR)
RCDSO Standards of Practice
14-11-24
27
§ “3. Oral Administration of a Single Sedative Drug with Nitrous Oxide and Oxygen Additional Responsibilities (p. 9) – Must be specifically trained, evaluated, and received
documentation of competency – Slow titration of nitrous oxide to avoid exceeding
minimal sedation – Continuous pulse oximeter monitoring – Audible audio output and alarms at all times
RCDSO Standards of Practice Written Record
§ Updated MH § Pre-operative vital signs § Confirm NPO § Confirm Ride (if BDZ) § Drug, dose, duration of sedation § Post-operative vital signs § Discharge criteria met § Discharged to responsible adult (if BDZ)
Sample N2O Patient Record
§ Example: HH: See Sedation Consult form. Reviewed health history with XX; no changes. No solids since XX AM/PM, no liquids since XX AM/PM. Pre-op BP XXX/XX, HR XX, RR XX. Sedation start XX AM/PM. Nitrous oxide: X L Nitrous at XX % for XX minutes, followed by 100% oxygen for 5 minutes. Patient conscious and comfortable throughout. Sedation end XX AM/PM. Post-op BP XXX/XX, HR XX, RR XX. Post op instructions written and verbal given to XX. Discharged at XX AM/PM: Vital signs stable, awake, alert, ambulatory. !
Sample Oral Sedation Patient Record
§ Example: HH: See Sedation Consult form. Reviewed health history with XX; no changes. NPO since XX AM/PM, ride confirmed. Pre-op BP XXX/XX, HR XX, RR XX. Sedation start XX AM/PM. 0.25 mg triazolam po 45 min prior to procedure with good effect for minimal sedation (relaxed, comfortable). Pt immediately responsive to verbal commands throughout. Sedation end XX AM/PM. Post-op BP XXX/XX, HR XX, RR XX. Post op instructions written and verbal given to XX. Discharged at XX AM/PM to father (George) taxi. VSS: awake, alert, ambulatory. !
Sample Oral Sedation Patient Record
§ Example: HH: See Sedation Consult form. Reviewed health history with XX; no changes. NPO since XX AM/PM, ride confirmed. Pre-op BP XXX/XX, HR XX, RR XX. Sedation start XX AM/PM. 0.375 mg triazolam po 45 min prior to procedure with adequate effect for minimal sedation (anxiolyis, no hypnosis). Pt responded normally with voice and light touch throughout. Sedation end XX AM/PM. Post-op BP XXX/XX, HR XX, RR XX. Post op instructions written and verbal given to XX. Discharge at XX AM/PM to adult (sister) private car. VSS: awake, alert, ambulatory. !
Emergency Preparedness
14-11-24
28
§ “All dentists and office staff must be prepared to recognize and treat adverse responses using appropriate emergency equipment and appropriate and current drugs when necessary.” (p.3)
RCDSO Standards of Practice Professional Responsibilities
§ “Should the administration of any drug produce depression beyond that of conscious sedation, the dental procedure should be halted. Appropriate support procedures must be administered until the level of depression is no longer beyond that of conscious sedation, or until additional emergency assistance is effected.” (iii, p.6)
Sedation Emergency
§ (p.3) Written protocols for emergency procedures – Review with staff regularly
RCDSO Standards of Practice Professional Responsibilities
14-11-24
29
§ (p.3) BLS (CPR Level HCP) – Current certification strongly recommended
RCDSO Standards of Practice Professional Responsibilities
Why Recertify?
§ Evidence suggests the retention of BLS and ACLS knowledge and skills is poor – After a 1 day course, 1 year later MDs and
RNs show significant deterioration, with performance returning to pre-training levels Gass & Curry Can Med Assoc J 1983
– After BLS course, 6 months later no MD or RN performed all management steps correctly Kay & Mancini Crit Care Med 1986
Why Recertify?
§ Dental students trained in CPR not capable of managing a cardiac arrest 3 months later Laurent et al J Dent Educ 2009 – >50% judge themselves competent in CPR – 50% failure to check for circulation – 50% failure to deliver adequate compressions
§ Dentists trained in CPR lack knowledge and confidence Gonzaga et al Brazil Dent J 2003 – 59% judge themselves competent; but only 46% can
correctly identify BLS concepts
BLS: Circulation-Breathing-Airway
§ C: Circulation – Heart sends oxygen to brain
§ B: Breathing – Lungs send oxygen to blood for heart
§ A : Airway – Patent airway provides oxygen to lungs
Sedation can compromise all of these systems.
What matters is rescue
§ “It is reasonable for healthcare providers to tailor the sequence of rescue actions to the most likely cause” – AHA Guidelines 2010
14-11-24
30
Signs of Airway Obstruction
§ Snoring § Exaggerated Respiratory Effort
– Use of accessory muscles
§ (Wheezing) § (Stridor) § Absence of breath sounds
Head-Tilt Chin-Lift
Head-Tilt Chin-Lift UPPER AIRWAY ANATOMY
§ Upper airway obstructed by tongue in oropharynx
§ Head-tilt chin lift opens upper airway
Head tilt–chin lift.
. Circulation 2000;102:I-22-I-59
Copyright © American Heart Association, Inc. All rights reserved.
Jaw thrust without head tilt.
. Circulation 2000;102:I-22-I-59
Copyright © American Heart Association, Inc. All rights reserved.
14-11-24
31
§ Oropharyngeal airway may help to maintain patency
UPPER AIRWAY Oral Airway Insertion
Face shield.
. Circulation 2000;102:I-22-I-59
Copyright © American Heart Association, Inc. All rights reserved.
Mouth-to-mask, cephalic technique.
. Circulation 2000;102:I-22-I-59
Copyright © American Heart Association, Inc. All rights reserved.
One-rescuer use of the bag mask.
. Circulation 2000;102:I-22-I-59
Copyright © American Heart Association, Inc. All rights reserved.
Two-rescuer use of the bag mask.
. Circulation 2000;102:I-22-I-59
Copyright © American Heart Association, Inc. All rights reserved.
14-11-24
32
Putting it all together
Sedation Ready
§ “What’s my action list to be able to do minimal sedation in my office tomorrow?”
Patient Evaluation
q Current, updated medical history q Indication for sedation q Core Physical Exam (Vital Signs) q Core Medical History
q Functional Inquiry (RESP, CVS) q Airway assessment
q Assign ASA Status q Max LA Dose Calculation
Patient Preparation
q NPO (2 hrs nitrous, 4 hrs BDZ) q Ride (BDZ) q Written Post-operative instructions
Provider Preparation
q Appropriate Training q Current BLS (Healthcare provider) q Sedation Assistant
– Patient cannot be left unattended – You cannot be alone with the patient!
q Emergency Protocols
Facility Preparation
q Functioning equipment, maintained q Basic Medical Emergency Drugs q E-tank Oxygen (separate supply) q Ambubag (full face mask, with connectors) q Manual stethescope and sphygomanometers q Flumazenil (if using benzodiazepines) My additional Recommendations: q Pulse oximeter q Selection of oral airways
101 Elm Street Toronto ON M5G 1G6
Nitrous Oxide and Oxygen Sedation is a safe and effective method to limit anxiety and create relaxation. Follow these instructions carefully. They are for your safety.
BEFORE THE APPOINTMENT
1. DO NOT EAT OR DRINK: NO FOOD OR DRINK within 2 hours of your dental appointment. The last meal before your appointment should be a light, low-‐fat meal (avoid dairy, no fried fatty food). The last drink before your appointment should be water, clear juice (apple juice), or black coffee (avoid dairy or dairy substitutes) as these are easy to digest.
Last Meal -‐ Light, Low-‐Fat 2 HRs 1 Appointment LAST SOLID FOOD LAST DAIRY DRINK
NO FOOD NO DRINK
3. MEDICATIONS: Take all regular medications at their usual time, with sips of water only. In rare instances, you may be asked not to take a certain medication. If you are not sure, check with your student.
4. WHAT TO WEAR: Loose, comfortable clothing is best. Do not wear nail polish.
5. ILLNESS: If you become sick or ill at anytime leading up to your appointment, call your student. Report any health changes such as new medical diagnosis, new illness, cough/fever, cold or flu. Bring an updated medication list to your appointment and be prepared to answer questions about your health. AFTER THE APPOINTMENT
1. ACTIVITIES: Following the administration of 100% Oxygen for five minutes, you should be fully recovered from the sedation and can resume your normal activities.
2. FOOD AND DRINK: Depending on your dental treatment, you may need to modify your diet. It is important to resume fluid intake after your appointment to prevent dehydration. Make sure you resume drinking following your sedation. Start with small sips of water and drink more as able.
Student Name: ______________________________________________________________
Daytime Phone: 416-‐979-‐4900 Ext. ___________ OR ________________________________
After hours or in an emergency, contact your nearest hospital emergency department.
PATIENT INSTRUCTIONS Nitrous Oxide and Oxygen Conscious (Minimal) Sedation
101 Elm Street Toronto ON M5G 1G6
Oral Conscious Sedation is a safe and effective method to limit anxiety and create relaxation.
Follow these instructions carefully. They are for your safety. BEFORE THE APPOINTMENT
1. MAKE PLANS FOR GETTING HOME: You will not be able to drive after your appointment. Under no circumstances may you use public transportation. You may only go home in 1) a private vehicle or 2) a taxi. You must have a responsible adult to escort you home. You must go directly to a place where you can rest.
You escort should arrive to _____________________________________ at _______________ to pick you up.
2. DO NOT EAT OR DRINK: For best absorption of the sedative medication. do not eat within 4 hours of your dental appointment. The last meal before your appointment should be a light, low-‐fat meal (avoid dairy, no fried fatty food). WATER, CLEAR JUICE, and BLACK COFFEE (NO DAIRY or dairy substitutes) are easy to digest and allowed up to 2 hours before your appointment. NO FOOD OR DRINK within 2 hours of your appointment.
Last Meal – Light, Low-‐Fat 4 HRs 3 2 HRs 1 Appointment LAST SOLID FOOD LAST DAIRY DRINK
NO FOOD Water, clear juice, black coffee ONLY
NO FOOD NO DRINK
3. MEDICATIONS: Take all regular medications at their usual time, with sips of water only. In rare instances, you may be asked not to take a certain medication. If you are not sure, check with your student.
4. WHAT TO WEAR: Loose, comfortable clothing is best. Do not wear nail polish.
5. ILLNESS: If you become sick or ill at anytime leading up to your appointment, call your student. Report any health changes such as new medical diagnosis, new illness, cough/fever, cold or flu. Bring an updated medication list to your appointment and be prepared to answer questions about your health. AFTER THE APPOINTMENT
1. ACTIVITIES: After your appointment, your motor coordination and cognitive function will be impaired. You may not operate a motor vehicle or machinery, consume alcohol, engage in decision-‐making, business transactions, or online social media for 18 hours, or longer if dizziness/drowsiness persists. Rest is best.
2. FOOD AND DRINK: Depending on your dental treatment, you may need to modify your diet. It is important to resume fluid intake after your appointment to prevent dehydration. Make sure you resume drinking following your sedation. Start with small sips of water and drink more as able.
3. SEEK ADVICE: If you have difficulty breathing, nausea or vomiting that persists beyond 2 hours, a sensation of dizziness or drowsiness 6-‐8 hours after your appointment, or any other matter that causes you concern. Student Name: ____________________________________________________________________________
Daytime Phone: 416-‐979-‐4900 Ext. ___________ OR ______________________________________________ After hours or in an emergency, please contact your nearest hospital emergency department.
PATIENT INSTRUCTIONS Oral Conscious (Minimal) Sedation
Ora
l Co
nsc
iou
s Se
dat
ion
Age
nts
: P
har
mac
olo
gy &
Su
gge
ste
d R
egi
me
ns
Dru
g
Tim
e (
ho
urs
) A
vaila
ble
Ora
l (P
O)
Pre
par
atio
ns
Ora
l (P
O)
Do
se
Ran
ge
For
Ad
ult
Pat
ien
ts
Ap
pro
xim
ate
Do
ses
for
Ad
ult
P
atie
nts
, ASA
I o
r II
* B
est
fo
r d
en
tal
app
oin
tme
nt
du
rati
on
s
On
set
of
Act
ion
Pe
ak
Seru
m
Co
nce
ntr
atio
n
Du
rati
on
o
f A
ctio
n
Elim
inat
ion
H
alf-
Life
Min
imal
Se
dat
ion
M
od
era
te
Sed
atio
n
Nig
ht
be
fore
Tria
zola
m
(Fo
rme
rly
Halcion™)
0.5
- 1
1
- 2
~2
1
.5 -
5.5
0
.12
5 a
nd
0.2
5
mg
tab
lets
0
.12
5 -
0.5
mg
(0.0
04
mg/
kg)
0.1
25
–
0.2
5 m
g 0
.37
5 -
0
.50
mg
0
.12
5 -
0
.25
mg
< 3
hrs
Dia
zep
am
Valium™
0
.5 -
1
0.5
- 2
2
- 4
2
0 -
80ǂ
2
, 5, a
nd
10
mg
tab
lets
1
0 -
30
mg
(0.0
65
- 0
.3 m
g/kg
) 1
0 -
15
mg
20
- 3
0 m
g 5
-10
mg
> 2
hrs
Lora
zep
am
Ativan™
1
- 2
1
- 6
U
p t
o 8
1
0 -
20
0
.5, 1
an
d 2
mg
o
ral a
nd
SL
tab
lets
0.5
- 3
mg
(0
.02
mg/
kg)
0.5
- 1
mg
2 -
3 m
g -
> 3
hrs
Alp
razo
lam
Xan
ax™
1
- 1
.5
1 -
2 4
- 6
6
- 3
0
0.2
5, 0
.5, 1
, an
d
2 m
g ta
ble
ts
0.2
5 -
0.5
mg
0.2
5 m
g 0
.5 m
g 0
.25
mg
> 3
hrs
Tem
aze
pam
**
Restoril™
0
.5 -
1
1.2
-1
.6
~4
3.5
- 1
8.4
1
5 a
nd
30
mg
cap
sule
s 7
.5 -
30
mg
15
mg
20
- 3
0 m
g -
Dat
a n
ot
avai
lab
le
Oxa
zep
am**
Oxp
am™
~1
~2
~3
~8
10
, 15
an
d 3
0 m
g ta
ble
ts
10
- 3
0m
g 1
0 -
15
mg
15
- 3
0 m
g -
Dat
a n
ot
avai
lab
le
* Fo
r p
atie
nts
wh
o a
re A
SA II
I or
eld
erly
, do
ses
sho
uld
be
red
uce
d. C
on
curr
ent
use
of
inh
alat
ion
al a
gen
ts s
uch
as
nit
rou
s o
xid
e s
ho
uld
be
titr
ated
ca
refu
lly t
o a
void
ove
rsed
atio
n. I
ncr
ease
d d
ura
tio
n o
f ac
tio
n in
th
ese
pat
ien
ts m
ay r
equ
ire
an in
crea
sed
du
rati
on
of
mo
nit
ori
ng.
** T
emaz
epam
an
d O
xaze
pam
hav
e b
een
po
orl
y st
ud
ied
in t
he
den
tal m
od
el. D
ose
s ar
e a
pp
roxi
mat
ion
s b
ased
on
th
eir
use
in a
lter
nat
e cl
inic
al
con
text
s.
ǂ C
orr
ela
tes
rou
ghly
wit
h p
atie
nt
age.
C Y
ara
sca
vitc
h, D
Mu
nya
l, D
Ha
as.
Dis
cip
line
of
Den
tal A
na
esth
esia
, Fa
cult
y o
f D
enti
stry
, Un
iver
sity
of
Toro
nto
©2
01
4. C
on
tact
au
tho
rs f
or
dis
trib
uti
on
oth
er t
ha
n p
erso
na
l use
.
top related